The Impact of GLP-1-Based Therapies on Cardiovascular Outcomes in Type 2 Diabetes: A Comprehensive Systematic Review and Network Meta-Analysis.

Diabetes, obesity & metabolism

Do GLP-1 Receptor Agonists Sabotage Fat Grafts? : A Scoping Review of GLP-1 Receptor Agonist Effects on Adipocyte Biology and Implications for Autologous Fat Transfer.

Aesthetic surgery journal

Semaglutide Injection in Indian Patients With Type 2 Diabetes Mellitus: A Randomised, Phase III, Active-Controlled Study.

Diabetes, obesity & metabolism

Evaluation of the Safety, Efficacy and Pharmacokinetics of BGM0504 in Chinese Adults With Type 2 Diabetes: A Multicentre, Randomised, Controlled and Double-Blind Phase II Trial.

Diabetes, obesity & metabolism

Retrospective Assessment of Food Noise Changes After Initiation of Injectable Semaglutide for Weight Management in the USA: The INFORM Survey.

Advances in therapy

Real-World Effectiveness of Tirzepatide in Japanese Patients with Type 2 Diabetes: A Multicenter Retrospective Observational Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders

IgG Fc-Binding Motif-Conjugated Exendin-4: A Long-Acting Hypoglycemic Agent via Broad-Spectrum Antibody Engagement for Type 2 Diabetes Therapy.

Bioconjugate chemistry

[Advances in Anti-Dementia Therapies in Older Adults].

Deutsche medizinische Wochenschrift (1946)

Popular obesity medications significantly lower overall cancer risk, study finds. The breakthrough class of obesity medications, including GLP-1 receptor agonists like semaglutide and dual GLP-1/GIP receptor agonists like tirzepatide, continue to make waves in modern medicine. https://t.co/Bul3Icqy4F

📢 ผลเสียของการปักกาที่ไม่มีใครเตือน‼️ ⛔ระวังสูญเสียมวลกล้ามเนื้อและกระดูกพรุน ​ยากลุ่ม GLP-1 receptor agonists คือยาจำพวก เซมากลูไทด์ (Semaglutide - ชื่อการค้า Ozempic, Wegovy) และยาทิรเซพาไทด์ (Tirzepatide - ชื่อการค้า Mounjaro, Zepbound) จากการวิจัยภายใน 52 อาทิตย์ https://t.co/MoXEVORcgI

RT @afshineemrani: 2/5 The study matched patients on GLP-1 receptor agonists — semaglutide, tirzepatide, liraglutide, and others — against…

RT @afshineemrani: 2/5 The study matched patients on GLP-1 receptor agonists — semaglutide, tirzepatide, liraglutide, and others — against…

RT @afshineemrani: 2/5 The study matched patients on GLP-1 receptor agonists — semaglutide, tirzepatide, liraglutide, and others — against…

RT @afshineemrani: 2/5 The study matched patients on GLP-1 receptor agonists — semaglutide, tirzepatide, liraglutide, and others — against…

@nicknorwitz Imagine knee or shoulder surgery along with IV drip of BPC-157 pre, during, and post surgery recovery. 24hrs of peptide therapy. Hospital and fda approved. Maybe hgh and IGF as well.

RT @gemoscatelli: Fastest growing business/sales in 2026: weight loss, obesity, diabetes, GIP/GLP-1 agonists (tirzepatide and semaglutide)…